US stocks are soaring on a euphoric Wall Street after President Trump said he would temporarily back off on most of his global tariffs.

AstraZenca is testing a once-daily PCSK9 inhibitor, currently known as AZD0780. After 12 weeks of use alongside standard ...

Bernstein analyst Florent Cespedes maintained a Hold rating on Merck KGaA (0O14 – Research Report) today and set a price target of €168.00. The ...

Leaders at Merck & Co. Inc. are facing a new derivative shareholder lawsuit over allegations that they made misleading ...

Global drugmakers' stocks dropped across the board after U.S. President Donald Trump reiterated plans for a "major" tariff on ...

Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...

Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...

President Donald Trump announced a 90-day pause on all tariffs except for those against China, which he said would now rise ...

DelveInsight's Merkel Cell Carcinoma Market Insights report includes a comprehensive understanding of current treatment practices, Merkel cell carcinoma emerging drugs, market share of individual ...